(Circulation. 1996;93:1201-1205.)
© 1996 American Heart Association, Inc.
Articles |
Increased Shear Stress Overcomes the Antithrombotic Platelet Inhibitory Effect of Aspirin in Stenosed Dog Coronary Arteries
From the Cardiology Section, University of Wisconsin-Madison.
Correspondence to John D. Folts, PhD, FACC, Director, Coronary Thrombosis Research Laboratory, University of Wisconsin-Madison, Cardiology Section, H6/379 CSC, 600 Highland Ave, Madison, WI 53792.
Background Shear stress is one of the known platelet activating mechanisms that leads to thrombosis. Increased shear stress has also been postulated to reverse the antithrombotic effect of some drugs such as aspirin (ASA).
Methods and Results Experiments were conducted in five dogs to determine the minimal shear stress levels that produce acute platelet thrombus formation in mechanically stenosed arteries and the increase in shear required to reverse the antithrombotic effect of ASA. After intimal and medial damage, stenosis was produced in the circumflex coronary artery. We used the finite-difference numerical solution of the Navier-Stokes equation to determine the wall shear stresses in the area of stenosis. At 70±6% coronary diameter reduction, cyclic flow reductions (CFRs) caused by acute platelet thrombus formation were observed in the stenosed lumen. At this level of stenosis, the shear stress was 144±15 Pa. ASA given at a dose of 5 mg/kg IV inhibited in vivo acute platelet-mediated thrombus formation and abolished CFRs in all dogs. However, increasing the stenosis level to 80±5% caused the CFRs to return. The shear stress increased with the increased level of stenosis to 226±22 Pa. Thus, an average 10% increase in diameter narrowing caused a 56±20% increase in shear stress (P<.005) and renewed platelet activation and thrombus formation despite ASA pretreatment.
Conclusions Individuals who take ASA daily to prevent coronary artery thrombus formation may not be well protected when a change in hemodynamics, such as an acute hypertensive episode, or an increase in stenosis severity due to a ruptured atherosclerotic plaque causes an increase in shear stress.
Key Words: thrombosis • stenosis • aspirin
This article has been cited by other articles:
 |
|
 |
|
  H. E. Speich, S. Grgurevich, T. J. Kueter, A. D. Earhart, S. M. Slack, and L. K. Jennings Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress Am J Physiol Cell Physiol, October 1, 2008; 295(4): C1045 - C1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Borgdorff, G. J. Tangelder, and W. J. Paulus Cyclooxygenase-2 Inhibitors Enhance Shear Stress-Induced Platelet Aggregation J. Am. Coll. Cardiol., August 15, 2006; 48(4): 817 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Borgdorff and G. J. Tangelder Pump-induced platelet aggregation with subsequent hypotension: Its mechanism and prevention with clopidogrel J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 813 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Freedman Molecular Regulation of Platelet-Dependent Thrombosis Circulation, October 25, 2005; 112(17): 2725 - 2734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sanderson, J. Emery, T. Baglin, and A.-L. Kinmonth Narrative Review: Aspirin Resistance and Its Clinical Implications Ann Intern Med, March 1, 2005; 142(5): 370 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Houel, E. Mazoyer, B. Boval, M. Kirsch, E. Vermes, L. Drouet, and D. Y. Loisance Platelet activation and aggregation profile in prolonged external ventricular support J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 197 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Marret, P. Bonnin, E. Mazoyer, B. Riou, T. Jacobs, P. Coriat, and C.-M. Samama The Effects of a Polymerized Bovine-Derived Hemoglobin Solution in a Rabbit Model of Arterial Thrombosis and Bleeding Anesth. Analg., March 1, 2004; 98(3): 604 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Houel, E. Mazoyer, M. Kirsch, B. Boval, L. Drouet, and D. Y. Loisance Resistance to aspirin after external ventricular assist device implantation J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1636 - 1637. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Resendiz, S. Feng, G. Ji, K. A. Francis, M. C. Berndt, and M. H. Kroll Purinergic P2Y12 Receptor Blockade Inhibits Shear-Induced Platelet Phosphatidylinositol 3-Kinase Activation Mol. Pharmacol., March 1, 2003; 63(3): 639 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Scrutinio, C. Cimminiello, E. Marubini, M. Vittoria Pitzalis, M. Di Biase, P. Rizzon, and the STAMI Group Ticlopidine versus aspirin after myocardial infarction (stami) trial J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1259 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. W. Broeders, G.-J. Tangelder, D. W. Slaaf, R. S. Reneman, and M. G. A. o. Egbrink Endogenous Nitric Oxide and Prostaglandins Synergistically Counteract Thromboembolism in Arterioles but Not in Venules Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Altman, A. Scazziota, J. Rouvier, and C. Gonzalez Effects of Ticlopidine or Ticlopidine Plus Aspirin on Platelet Aggregation and ATP Release in Normal Volunteers: Why Aspirin Improves Ticlopidine Antiplatelet Activity Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(4): 243 - 246. [Abstract] [PDF]
|
|
|
|
|
|
J. D. Folts, A. I. Schafer, J. Loscalzo, J. T. Willerson, and J. E. Muller A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials J. Am. Coll. Cardiol., February 1, 1999; 33(2): 295 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Irani, Y. Pham, L. D. Coleman, C. Roos, G. E. Cooke, A. Miodovnik, N. Karim, C. C. Wilhide, P. F. Bray, and P. J. Goldschmidt-Clermont Priming of Platelet {alpha}IIbß3 by Oxidants Is Associated With Tyrosine Phosphorylation of ß3 Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1698 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Altman, A. Scazziota, J. Rouvier, M. T. Santos, J. Valles, J. Aznar, A. J. Marcus, and M. J. Broekman Daily 50 mg or 500 mg Aspirin Does Not Affect the Cooperation of Arachidonic Acid and ADP on Platelet Aggregation • Response Circulation, January 13, 1998; 97(1): 118 - 119. [Full Text]
|
|
|
|
|
|
R. Altman Controversies in Antithrombotic Therapy in Cardiovascular Diseases Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 11 - 24. [Abstract] [PDF]
|
|
|
|
|
|
M. A. W. Broeders, G.-J. Tangelder, D. W. Slaaf, R. S. Reneman, and M. G. A. oude Egbrink Endogenous Nitric Oxide Protects Against Thromboembolism in Venules But Not in Arterioles Arterioscler Thromb Vasc Biol, January 1, 1998; 18(1): 139 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rocca and G. A. FitzGerald Simply Read: Erythrocytes Modulate Platelet Function: Should We Rethink the Way We Give Aspirin? Circulation, January 7, 1997; 95(1): 11 - 13. [Full Text]
|
|